KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Operating Leases: 2020-2025

Historic Operating Leases for Twist Bioscience (TWST) over the last 6 years, with Sep 2025 value amounting to $75.6 million.

  • Twist Bioscience's Operating Leases rose 7.62% to $75.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.6 million, marking a year-over-year increase of 7.62%. This contributed to the annual value of $75.6 million for FY2025, which is 7.62% up from last year.
  • Twist Bioscience's Operating Leases amounted to $75.6 million in FY2025, which was up 7.62% from $70.2 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Operating Leases ranged from a high of $81.3 million in FY2022 and a low of $53.2 million during FY2021.
  • For the 3-year period, Twist Bioscience's Operating Leases averaged around $75.0 million, with its median value being $75.6 million (2025).
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 114.02% in 2021, then dropped by 11.31% in 2024.
  • Over the past 5 years, Twist Bioscience's Operating Leases (Yearly) stood at $53.2 million in 2021, then soared by 52.89% to $81.3 million in 2022, then fell by 2.58% to $79.2 million in 2023, then dropped by 11.31% to $70.2 million in 2024, then increased by 7.62% to $75.6 million in 2025.